MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-κB activation

Oncogene

Volumn 22, Issue 49, 2003, Pages 7774-7780

  Nawata, Ryouhei ^a   Yujiri, Toshiaki ^a   Nakamura, Yukinori ^a   Ariyoshi, Koichi ^a   Takahashi, Toru ^a   Sato, Yutaka ^a   Oka, Yoshitomo ^b   Tanizawa, Yukio ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bcr Abl; MEK kinase 1; NF B

Indexed keywords

BCR ABL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL PROTECTION; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; LEUKEMIA CELL LINE; MUTANT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE; GENES, ABL; INHIBITOR OF APOPTOSIS PROTEINS; LEUKEMIA, MYELOID, CHRONIC; MAP KINASE KINASE KINASE 1; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA, MESSENGER;

ANIMALIA;

EID: 0345304900     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206901     Document Type: Article

References (38)

1. Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR and Bhalla K. (1998). Blood, 91, 1700-1705.
2. Burgess GS, Williamson EA, Cripe LD, Litz-Jackson S, Bhatt JA, Stanley K, Stewart MJ, Kraft AS, Nakshatri H and Boswell HS. (1998). Blood, 92, 2450-2460.
3. Cardone MH, Salvesen GS, Widmann C, Johnson G and Frisch SM. (1997). Cell, 90, 315-323.
4. Christerson LB, Vanderbilt CA and Cobb MH. (1999). Cell Motil. Cytoskeleton, 43, 186-198.
5. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH and Ballard DW. (1997). Proc. Natl. Acad. Sci. USA, 94, 10057-10062.
6. Cortez D, Kadlec L and Pendergast AM. (1995). Mol. Cell Biol., 15, 5531-5541.
7. Crook NE, Clem RJ and Miller LK. (1993). J. Virol., 67, 2168-2174.
8. Daley GQ and Baltimore D. (1988). Proc. Natl. Acad. Sci. USA, 85, 9312-9316.
9. Deininger MW, Goldman JM and Melo JV. (2000). Blood, 96, 3343-3356.
10. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, Roth KA and Weintraub SJ. (2002). Cell, 111, 51-62.
11. Druker BJ. (2002). Oncogene, 21, 8541-8546.
12. Dubrez L, Eymin B, Sordet O, Droin N, Turhan AG and Solary E. (1998). Blood, 91, 2415-2422.
13. Fanger GR, Johnson NL and Johnson GL. (1997). EMBO J. 16, 4961-4972.
14. Gibson S, Widmann C and Johnson GL. (1999). J. Biol. Chem., 274, 10916-10922.
15. Gibson SB, Oyer R, Spalding AC, Anderson SM and Johnson GL. (2000). Mol. Cell Biol., 20, 205-212.
16. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN and Sawyers CL. (2001). Science, 293, 876-880.
17. Hirano T, Shino Y, Saito T, Komoda F, Okutomi Y, Takeda A, Ishihara T, Yamaguchi T, Saisho H and Shirasawa H. (2002). Oncogene, 21, 5923-5928.
18. Ilaria Jr RL and Van Etten RA. (1996). J. Biol. Chem., 271, 31704-31710.
19. Kabarowski JH, Allen PB and Wiedemann LM. (1994). EMBO J., 13, 5887-5895.
20. Kharbanda S, Pandey P, Yamauchi T, Kumar S, Kaneki M, Kumar V, Bharti A, Yuan ZM, Ghanem L, Rana A, Weichselbaum R, Johnson G and Kufe D. (2000). Mol. Cell Biol., 20, 4979-4989.
21. Lee FS, Hagler J, Chen ZJ and Maniatis T. (1997). Cell, 88, 213-222.
22. Lu Z, Xu S, Joazeiro C, Cobb MH and Hunter T. (2002). Mol. Cell, 9, 945-956.
23. Makin G and Dive C. (2001). Trends Cell. Biol., 11, S22-S26.
24. Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD and Druker BJ. (1994). J. Biol. Chem., 269, 22925-22928.
25. Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL, Gorman DM, Nolan GP, Miyajima A and Kitamura T. (1996). Exp. Hematol., 24, 324-329.
26. Raitano AB, Halpern JR, Hambuch TM and Sawyers CL. (1995). Proc. Natl. Acad. Sci. USA, 92, 11746-11750.
27. Reuther JY, Reuther GW, Cortez D, Pendergast AM and Baldwin Jr AS. (1998). Genes Dev., 12, 968-981.
28. Salgia R, Li JL, Ewaniuk DS, Pear W, Pisick E, Burky SA, Ernst T, Sattler M, Chen LB and Griffin JD. (1997). J. Clin. Invest., 100, 46-57.
29. Salvesen GS and Duckett CS. (2002). Nat. Rev. Mol. Cell Biol., 3, 401-410.
30. Shuai K, Halpern J, ten Hoeve J, Rao X and Sawyers CL. (1996). Oncogene, 13, 247-254.
31. Skorski T. (2002). Oncogene, 21, 8591-8604.
32. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN and Calabretta B. (1997). EMBO J., 16, 6151-6161.
33. Widmann C, Gerwins P, Johnson NL, Jarpe MB and Johnson GL. (1998a). Mol. Cell Biol., 18, 2416-2429.
34. Widmann C, Gibson S and Johnson GL. (1998b). J. Biol. Chem., 273, 7141-7147.
35. Yujiri T, Fanger GR, Garrington TP, Schlesinger TK, Gibson S and Johnson GL. (1999). J. Biol. Chem., 274, 12605-12610.
36. Yujiri T, Nawata R, Takahashi T, Sato Y, Tanizawa Y, Kitamura T and Oka Y. (2003). J. Biol. Chem., 278, 3846-3851.
37. Yujiri T, Sather S, Fanger GR and Johnson GL. (1998). Science, 282, 1911-1914.
38. Yujiri T, Ware M, Widmann C, Oyer R, Russell D, Chan E, Zaitsu Y, Clarke P, Tyler K, Oka Y, Fanger GR, Henson P and Johnson GL. (2000). Proc. Natl. Acad. Sci. USA, 97, 7272-7277.